PEMOA38	People living with HIV who are receiving suppressive antiretroviral therapy mount strong humoral responses to two and three doses of COVID-19 vaccine	Poster exhibition	SARS-Cov2 vaccines
PEMOB27	Persistent low-level viremia in the era of dolutegravir in four African countries	Poster exhibition	Adherence
PEMOB28	Safety outcomes among HIV-1 positive Zambian adults receiving Tenofovir Alafenamide combined with Dolutegravir: results from the VISEND clinical trial	Poster exhibition	Pregnancy (clinical management issues and pharmacokinetics) and contraception
PEMOB29	Selection of cabotegravir dosing regimens for HIV treatment and pre-exposure prophylaxis (PrEP) in adolescents by Leveraging adult data	Poster exhibition	Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations
PEMOB30	Optimizing DTG uptake amongst children living with HIV in Ikom rural communities attending ART clinic at Comprehensive Health Center (CHC) Ikom, Cross River State	Poster exhibition	ARV management strategies in paediatric and adolescent populations
PEMOB31	The cognitive development of children born to adolescent mothers ' does child HIV status matter?	Poster exhibition	Mental health and neurocognition in paediatric and adolescent populations
PEMOB32	No difference in prevalence of TB infection among infants in two Southern African cohorts by in utero HIV exposure status	Poster exhibition	HIV-exposed uninfected children
PEMOB33	Causes of death and hospitalisations in a cohort of sex workers in South Africa	Poster exhibition	Clinical issues in sex workers
PEMOB34	Prevalence and risk factors for anal dysplasia among men who have sex with men living with HIV: the HPV Screening and Vaccine Evaluation (HPV-SAVE) Study	Poster exhibition	Malignancies (AIDS and non-AIDS)
PEMOB35	Addressing sexual health in trans masculinities: lessons learned from TransCITAR transgender cohort study in Argentina	Poster exhibition	Clinical issues in transgender people